These results suggested that PLOD3 is secreted from lung cancer cells in vivo and in vitro, and PLOD3 is markedly correlated with a poor prognosis in lung cancer patients, playing important roles in the metastasis and lung cancer progression. This evidence concerns the gene PLOD3 and lung carcinoma.